Original Article a Novel Long Noncoding RNA Lncwdr26 Suppresses the Growth and Metastasis of Hepatocellular Carcinoma Cells Through Interaction with SIX3
Total Page:16
File Type:pdf, Size:1020Kb
Am J Cancer Res 2018;8(4):688-698 www.ajcr.us /ISSN:2156-6976/ajcr0067472 Original Article A novel long noncoding RNA lncWDR26 suppresses the growth and metastasis of hepatocellular carcinoma cells through interaction with SIX3 Baosheng Chen Department of Second General Surgery, Hebei Cangzhou Central Hospital, Cangzhou 061000, Heibei Province, China Received October 18, 2017; Accepted November 1, 2017; Epub April 1, 2018; Published April 15, 2018 Abstract: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Long non- coding RNAs (lncRNAs) are involved in the tumorigenesis and progression of some cancers. However, only a handful of lncRNAs have been functionally identified in HCC. In the present study, we identified a novel functional lncRNA in HCC, termed lncWDR26 (GenBank Accession no. RP11-365O16). Here, we reported that lncWDR26 was signifi- cantly downregulated in HCC tissues and cells. Moreover, decreased lncWDR26 expression correlates with larger tumor size, higher clinical stage, and tumor metastasis, and also predicts poor prognosis in patients with HCC. In HCC cells, overexpression of lncWDR26 inhibited growth and metastasis, both in vitro and in vivo. Mechanistically, lncWDR26 suppressed HCC growth and metastasis by inhibiting WDR26 transcription. Notably, lncWDR26 was as- sociated with SIX homeobox 3 (SIX3), and this association was required for the repression of WDR26 transcription. Together, these results indicate that lncWDR26 is a tumor suppressor lncRNA that promotes tumor progression, leading us to propose that lncRNAs may serve as key regulatory hubs in HCC progression. Keywords: WDR26, SIX3, growth, metastasis Introduction RNA transcripts in the genome without protein- coding potential, have been reported to be Hepatocellular carcinoma (HCC) is the third critical regulators in modulating cancer malig- leading cause of cancer-related deaths world- nancies [4-6]. The mechanisms of actions of wide. Liver resection is still the best therapeu- well-studied lncRNAs are known to modify chro- tic strategy to treat HCC, with a 5-year survival matin structure and regulate gene expression rate of approximately 30% [1]. The prognosis of in cis or trans manner [7]. Dysregulation of patients with HCC remains poor despite the lncRNAs has been correlated to tumorigenesis advancement in HCC treatment. Thus, under- and cancer metastasis [8, 9]. In HCC, a handful standing the molecular mechanisms of hepato- of lncRNAs have been functionally identified. carcinogenesis and identifying novel prognos- For example, HOTAIR [10], lncRNA-ATB, UFC1 tic molecular markers can promote the devel- [11], and MALAT1 [12] were found to be overex- opment of appropriate therapeutic strategies pressed in HCC tissues. Overexpression of earlier in the course of this cancer. these lncRNAs is correlated with poor survival of patients, and plays an important role in the The noncoding RNAs that are the predominant development of HCC. Thus, these RNAs may act transcripts in the mammalian genome exceed as “onco-lncRNAs”. In contrast, lncRNA MEG3 the number of protein-coding genes. It has be- [13] and GAS5 [14] were downregulated in HCC en reported that abnormal expression of small tissues compared to normal liver tissues. Re- noncoding RNAs (ncRNAs), especially microR- storation of expression of these lncRNAs sup- NAs, contributes to the pathogenesis of HCC presses the proliferation, migration, and inva- [2, 3]. More recently, a new class of ncRNAs, sion of HCC cells. Therefore, they may function known as long noncoding RNAs (lncRNA; larger as “tumor suppressor lncRNAs”. Although thou- than 200 nucleotides), which are endogenous sands of lncRNAs have been annotated, only a lncWDR26 and HCC few lncRNAs have been functionally charac- were separated by SDS-PAGE and then trans- terized. ferred onto PVDF membranes. The membranes were blocked and incubated with anti-SIX3 In this study, we characterized the pathologi- (Abcam, Cambridge, MA, USA), or WDR26 (Ab- cal relevance of lncRNA WD repeat domain 26 cam, Cambridge, MA, USA) or GAPDH antibody (lncWDR26) (GenBank Accession no. RP11-36- (Santa Cruz, CA) at 4°C overnight. After being 5O16) in HCC growth and metastasis. Its expre- washed, the membranes were incubated with ssion was analyzed by qRT-PCR using tissue HRP-conjugated anti-IgG (Santa Cruz, CA). Sig- samples from 82 patients with HCC. Further nal was detected by an ECL system (Amersham mechanistic investigations into the function of Pharmacia, Piscataway, NJ). lncWDR26 in HCC were performed through gain-of-function studies, RNA immunoprecipita- Quantitative real-time PCR (qRT-PCR) tion (RIP) assays, and RNA pull-down assays, through which we demonstrated that the inter- Total RNA was isolated using the RNeasy Mini action between lncWDR26 and SIX homeobox Kit (QIAGEN) according to the manufacturer’s 3 (SIX3) was associated with HCC formation instructions. 1 μg of total RNA was reversely and progression. transcribed to cDNA by using EasyScript One- Step gDNA Removal and cDNA Synthesis Materials and methods (Transgen, Beijing, China). qRT-PCR was per- formed on the Step-One Plus Detection System Cell culture (Applied Biosystems, USA). Relative expression levels were calculated as ratios normalized Six HCC cell lines (SMMC-7721, PLC/PRF/5, against those of GAPDH. Comparative quantifi- Huh7, SK-Hep-1 and Hep3B) and a normal cation was determined using the 2-ΔΔCt method. liver cell line (LO2) were obtained from Cell Primers were provided as follow: GAPDH-R: Bank of Chinese Academy of Sciences. Cells 5’-GATTCCACCCATGHCCAAATTC-3’, GAPDH-R: were cultured in DMEM (Gibco) supplemented 5’-CTGGAAGATGGTGATGGGATT-3’; lncWDR26- with 10% FBS (Gibco) and 1% penicillin-strepto- F: 5’-AGACCTGACCTGGAATGAGA-3’, lncWDR26- mycin (Hyclone). R: 5’-TGGGCAACAGAGCAAGATT-3’; WDR26-F: 5’-CATGGAAGGAGACTGGGATAAG-3’, WDR26-R: Tissue samples 5’-GATTTCAAGTGCGCCTCTTAC-3’. 82 paired HCC and corresponding normal liver Isolation of cytoplasmic and nuclear tissue samples were collected during HCC sur- gery. All of the patients gave informed consent Cytoplasmic and nuclear RNA were isolated for their tissues to be used for this research. and purified using the Cytoplasmic & Nuclear Recommendations of the Declaration of Hel- RNA Purification Kit (Norgen, Belmont, CA) ac- sinki for biomedical research involving human cording to its manual. subjects were also followed. Ethical approval for the study was obtained from Ethics Com- 5’ and 3’ rapid amplification of cDNA ends mittee of Cangzhou Central Hospital. (RACE) Cell proliferation detection We used the 5’-RACE and 3’-RACE analyses to determine the transcriptional initiation and ter- 3×103 cells per well were seeded in the 96- mination sites of lncWDR26 using a SMARTer™ well plate and incubated for different time RACE cDNA Amplification Kit (Clontech, Palo point, respectively. Cell proliferation was mea- Alto, CA) according to the manufacturer’s in- sured with a Cell Counting Kit-8 (CCK-8) (Be- structions. yotime, Shanghai, China), following the manu- facturer’s instructions. Absorbance was mea- Cell transfection sured at 450 nm using Elx800 Reader (Bio-Tek Instruments, VT, USA). LncWDR26 transcript was determined by a RACE assay. Cells were transfected with lentivi- Western blot ral particles expressing full-length human lnc- WDR26 sequence or an empty lentiviral vector The cells were lysed with RIPA buffer (Beyotime control. After 48 hours, stable clones were se- Biothechnology, Beijing, China). Protein lysates lected for 1 week by using puromycin. We con- 689 Am J Cancer Res 2018;8(4):688-698 lncWDR26 and HCC structed lentivirus-based short hairpin RNA RNA pull-down and mass spectrometry assay (shRNA) expression constructs into pLKO.1 vec- tor (Addgene) to knockdown lncWDR26 expres- RNA pull-down was performed as previously sion. Cells were transfected with either of lenti- described [15]. In vitro biotin-labeled RNAs (lnc- viral vectors encoding specific shRNA sequence WDR26 and its antisense RNA) were tran- or the negative control vector (scramble shRNA, scribed with the biotin RNA labeling mix (Roche) named Con). Following target sequences were and T7 RNA polymerase (Roche) treated with used: shlncWDR26: CCTGGAATGAGACTTGCAA; RNase-free DNase I (Promega) and purified shWDR26: CAGTCAGATGAGGATGTCA; shSIX3: with RNeasy Mini Kit (QIAGEN). Biotinylated CAAGTAGGCAACTGGTTTA. RNA was incubated with nuclear extracts of breast cancer cells, and pull-down proteins Cell cycle assay were run on SDS-PAGE gels. Mass spectrome- try followed. The cell cycle was analyzed using an in situ cell proliferation kit FLUOS (Roche) according to the RNA-FISH manufacturer’s instruction. The cell cycle distri- bution was analyzed by flow cytometry. The Fluorescence-conjugated lncWDR26 probes data were analyzed by FlowJo software (Tree were used for RNA-FISH. RNA-FISH was per- Star). formed by using RNA-FISH Kit (Boster, Wuhan, China) according to the standard protocol. Cells Apoptosis assay were observed with a FV1000 confocal laser microscope (Olympus). Cells were stained with fluorescein isothiocya- nate-conjugated Annexin V and 7-AAD (Apop- Tumor xenograft tosis Detection Kit, KeyGEN, Nanjing, China) according to the manufacturer’s instruction. Male nude mice (4-6-week old) were used for Cells were analyzed with flow cytometer, and xenograft assays. Cells (1×106) were trypsin- the data were studied using FlowJo software ized, harvested in PBS, and injected subcuta- (Tree Star). neously into the flank of the animals.